Proteome Sciences (LON:PRM) Posts Quarterly Earnings Results

Proteome Sciences (LON:PRM) issued its earnings results on Wednesday. The company reported GBX (1.04) earnings per share for the quarter, Digital Look Earnings reports. Proteome Sciences had a positive return on equity of 44.15% and a negative net margin of 73.62%.The firm had revenue of GBX 376 million during the quarter.

Proteome Sciences Stock Down 11.8%

Shares of LON PRM opened at GBX 1.24 on Friday. Proteome Sciences has a 12-month low of GBX 1.20 and a 12-month high of GBX 4.40. The company has a market cap of £4.33 million, a P/E ratio of -1.09 and a beta of 0.07. The company has a current ratio of 0.11, a quick ratio of 0.37 and a debt-to-equity ratio of -179.32. The stock has a fifty day moving average price of GBX 1.69 and a 200 day moving average price of GBX 2.02.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.